138 related articles for article (PubMed ID: 12406874)
41. T cell and B cell tolerance to GALalpha1,3GAL-expressing heart xenografts is achieved in alpha1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism.
Ohdan H; Yang YG; Swenson KG; Kitamura H; Sykes M
Transplantation; 2001 Jun; 71(11):1532-42. PubMed ID: 11435961
[TBL] [Abstract][Full Text] [Related]
42. Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection.
Yin DP; Sankary HN; Ma LL; Shen J; Qin Y; Blinder L; Williams JW; Chong AS
Transplantation; 2001 May; 71(10):1385-9. PubMed ID: 11391223
[TBL] [Abstract][Full Text] [Related]
43. Immune response to bovine pericardium implanted into α1,3-galactosyltransferase knockout mice: feasibility as an animal model for testing efficacy of anticalcification treatments of xenografts.
Lee C; Ahn H; Kim SH; Choi SY; Kim YJ
Eur J Cardiothorac Surg; 2012 Jul; 42(1):164-72. PubMed ID: 22223697
[TBL] [Abstract][Full Text] [Related]
44. Continued production of xenoimmune antibodies 6-8 years after clinical transplantation of fetal pig islet-like cell-clusters.
Lindeborg E; Kumagai-Braesch M; Tibell A; Möller E
Xenotransplantation; 2001 Nov; 8(4):273-83. PubMed ID: 11737853
[TBL] [Abstract][Full Text] [Related]
45. The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance.
Macher BA; Galili U
Biochim Biophys Acta; 2008 Feb; 1780(2):75-88. PubMed ID: 18047841
[TBL] [Abstract][Full Text] [Related]
46. Incidence and cytotoxicity of antibodies in cynomolgus monkeys directed to nonGal antigens, and their relevance for experimental models.
Rood PP; Hara H; Busch JL; Ezzelarab M; Zhu X; Ball S; Ayares D; Awwad M; Cooper DK
Transpl Int; 2006 Feb; 19(2):158-65. PubMed ID: 16441365
[TBL] [Abstract][Full Text] [Related]
47. Mac-1-negative B-1b phenotype of natural antibody-producing cells, including those responding to Gal alpha 1,3Gal epitopes in alpha 1,3-galactosyltransferase-deficient mice.
Ohdan H; Swenson KG; Kruger Gray HS; Yang YG; Xu Y; Thall AD; Sykes M
J Immunol; 2000 Nov; 165(10):5518-29. PubMed ID: 11067905
[TBL] [Abstract][Full Text] [Related]
48. Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells.
Kawahara T; Ohdan H; Zhao G; Yang YG; Sykes M
J Immunol; 2003 Nov; 171(10):5406-14. PubMed ID: 14607944
[TBL] [Abstract][Full Text] [Related]
49. Immunological property of antibodies against N-glycolylneuraminic acid epitopes in cytidine monophospho-N-acetylneuraminic acid hydroxylase-deficient mice.
Tahara H; Ide K; Basnet NB; Tanaka Y; Matsuda H; Takematsu H; Kozutsumi Y; Ohdan H
J Immunol; 2010 Mar; 184(6):3269-75. PubMed ID: 20173026
[TBL] [Abstract][Full Text] [Related]
50. The resistance of delayed xenograft rejection to alpha(1,3)-galactosyltransferase gene inactivation and CD4 depletion in a mouse-to-rat model.
Hansen AB; Kirkeby S; Aasted B; Dahl K; Hansen AK; Dieperink H; Svendsen M; Kemp E; Buschard K; D'Apice AJ
APMIS; 2003 Nov; 111(11):1019-26. PubMed ID: 14629268
[TBL] [Abstract][Full Text] [Related]
51. Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer.
Galili U
Cancer Immunol Immunother; 2004 Nov; 53(11):935-45. PubMed ID: 15205919
[TBL] [Abstract][Full Text] [Related]
52. Combination of decay-accelerating factor expression and alpha1,3-galactosyltransferase knockout affords added protection from human complement-mediated injury.
van Denderen BJ; Salvaris E; Romanella M; Aminian A; Katerelos M; Tange MJ; Pearse MJ; d'Apice AJ
Transplantation; 1997 Sep; 64(6):882-8. PubMed ID: 9326415
[TBL] [Abstract][Full Text] [Related]
53. Oral feeding with pig peripheral lymphocytes decreases the xenogeneic delayed type hypersensitivity reaction in galactosyltransferase knockout mice.
Lukes DJ; Cantu E; Gaca JG; Hallberg E; Karlsson-Parra A; Parker W; Olausson M; Davis RD
Transplant Proc; 2005 Oct; 37(8):3327-31. PubMed ID: 16298587
[TBL] [Abstract][Full Text] [Related]
54. Porcine and bovine cartilage transplants in cynomolgus monkey: II. Changes in anti-Gal response during chronic rejection.
Galili U; LaTemple DC; Walgenbach AW; Stone KR
Transplantation; 1997 Mar; 63(5):646-51. PubMed ID: 9075832
[TBL] [Abstract][Full Text] [Related]
55. Rapid recruitment and activation of macrophages by anti-Gal/α-Gal liposome interaction accelerates wound healing.
Wigglesworth KM; Racki WJ; Mishra R; Szomolanyi-Tsuda E; Greiner DL; Galili U
J Immunol; 2011 Apr; 186(7):4422-32. PubMed ID: 21357545
[TBL] [Abstract][Full Text] [Related]
56. The bacterial flora of alpha-Gal knockout mice express the alpha-Gal epitope comparable to wild type mice.
Dahl K; Kirkeby S; d'Apice AF; Mathiassen S; Hansen AK
Transpl Immunol; 2005 Mar; 14(1):9-16. PubMed ID: 15814276
[TBL] [Abstract][Full Text] [Related]
57. Intragraft gene expression profile associated with the induction of tolerance.
Doki T; Mello M; Mock D; Evans JM; Kearns-Jonker M
BMC Immunol; 2008 Feb; 9():5. PubMed ID: 18267024
[TBL] [Abstract][Full Text] [Related]
58. Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits.
Galili U
Immunology; 2013 Sep; 140(1):1-11. PubMed ID: 23578170
[TBL] [Abstract][Full Text] [Related]
59. In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha1,3galactosyltransferase gene.
Deriy L; Ogawa H; Gao GP; Galili U
Cancer Gene Ther; 2005 Jun; 12(6):528-39. PubMed ID: 15818383
[TBL] [Abstract][Full Text] [Related]
60. Conversion of tumors into autologous vaccines by intratumoral injection of α-Gal glycolipids that induce anti-Gal/α-Gal epitope interaction.
Galili U
Clin Dev Immunol; 2011; 2011():134020. PubMed ID: 22162709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
